RecruitingNCT06252948
Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders
Sponsor
Mayo Clinic
Enrollment
240 participants
Start Date
Dec 29, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
A Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Diagnosed with POEMS syndrome (newly diagnosed or in remission) or with newly diagnosed multiple myeloma (MM), monoclonal gammopathy of undetermined significance (MGUS), amyloid light chain (AL) amyloidosis or healthy controls from their households
Exclusion Criteria7
- Age under 18 years
- Pregnancy
- Substance abuse
- Antibiotics use or gastrointestinal endoscopy in the 3 months prior to the study participation
- Chronic gastrointestinal disorder
- Gastrointestinal surgeries in the past 2 years
- Chemotherapy (including anti-plasma cell treatment and steroids) or radiation treatment for cancer within the last 2 years or active cancer (other than plasma cell disorder)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNon-interventional study (observational)
Participants undergo stool sample collection, complete surveys, and have their medical record reviewed on study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06252948